(Q39132563)

English

Cross modulation between the androgen receptor axis and protocadherin-PC in mediating neuroendocrine transdifferentiation and therapeutic resistance of prostate cancer

scientific article published on July 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

Cross modulation between the androgen receptor axis and protocadherin-PC in mediating neuroendocrine transdifferentiation and therapeutic resistance of prostate cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Stéphane Terry

1

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

Pascale Maillé

2

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

Habiba Baaddi

3

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

Laurence Kheuang

4

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

Pascale Soyeux

5

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

Nathalie Nicolaiew

6

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

Jocelyn Ceraline

7

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

Virginie Firlej

8

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

Himisha Beltran

9

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

Yves Allory

10

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

Alexandre de la Taille

11

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

Francis Vacherot

12

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

publication date

1 July 2013

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

15

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

7

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

761-772

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

12 September 2017

Cancer statistics, 2012

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

12 September 2017

New therapies for castration-resistant prostate cancer: efficacy and safety

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

12 September 2017

Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

12 September 2017

Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

12 September 2017

An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

12 September 2017

Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

12 September 2017

Androgenic regulation of hedgehog signaling pathway components in prostate cancer cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

12 September 2017

Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

12 September 2017

Ionizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

12 September 2017

Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

12 September 2017

Neuroendocrine differentiation in prostate cancer: from lab to bedside

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

12 September 2017

Genetic analysis of neuroendocrine tumor cells in prostatic carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

12 September 2017

Androgen receptor in prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

12 September 2017

Molecular determinants of resistance to antiandrogen therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

12 September 2017

Ceramide accumulation is independent of camptothecin-induced apoptosis in prostate cancer LNCaP cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

12 September 2017

A history of prostate cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

12 September 2017

Bicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

12 September 2017

alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

12 September 2017

The development of androgen-independent prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

12 September 2017

Conservation of PCDHX in mammals; expression of human X/Y genes predominantly in brain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

12 September 2017

LNCaP model of human prostatic carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

12 September 2017

The human prostatic cancer cell line LNCaP and its derived sublines: an in vitro model for the study of androgen sensitivity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

12 September 2017

The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

12 September 2017

Neuroendocrine differentiation in human prostatic carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

12 September 2017

Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

12 September 2017

Increased expression of class III beta-tubulin in castration-resistant human prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

14 September 2017

Differential effects of prostate cancer therapeutics on neuroendocrine transdifferentiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

14 September 2017

Protocadherin-PC promotes androgen-independent prostate cancer cell growth.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

14 September 2017

Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

14 September 2017

A human- and male-specific protocadherin that acts through the wnt signaling pathway to induce neuroendocrine transdifferentiation of prostate cancer cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

14 September 2017

Myc confers androgen-independent prostate cancer cell growth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

14 September 2017

Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

14 September 2017

Transdifferentiation of prostate cancer cells to a neuroendocrine cell phenotype in vitro and in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

25 September 2017

A new human prostate carcinoma cell line, 22Rv1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

25 September 2017

An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

25 September 2017

Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

17 June 2018

The emergence of protocadherin-PC expression during the acquisition of apoptosis-resistance by prostate cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

17 June 2018

Implication of cell kinetic changes during the progression of human prostatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

17 June 2018

Application of the MTT assay to human prostate cancer cell lines in vitro: establishment of test conditions and assessment of hormone-stimulated growth and drug-induced cytostatic and cytotoxic effects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

17 June 2018

Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

21 August 2018

NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

21 August 2018

Androgen receptor outwits prostate cancer drugs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

21 August 2018

Androgen receptor represses the neuroendocrine transdifferentiation process in prostate cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

21 August 2018

Androgen-Independent Prostate Cancer Is a Heterogeneous Group of Diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689239

2 December 2018

Neuroendocrine differentiation in hormone refractory prostate cancer following androgen deprivation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23814488

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phorbol ester-induced apoptosis is accompanied by NGFI-A and c-fos activation in androgen-sensitive prostate cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23814488

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocrine-paracrine cell types in the prostate and prostatic adenocarcinoma are postmitotic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23814488

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroendocrine differentiation in prostatic carcinoma during hormonal treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/23814488

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comprehensive expression analysis of L-dopa decarboxylase and established neuroendocrine markers in neoadjuvant hormone-treated versus varying Gleason grade prostate tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/23814488

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical analysis of the proliferative activity of neuroendocrine tumors from various organs. Are there indications for a neuroendocrine tumor-carcinoma sequence?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23814488

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1593/NEO.122070

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39132563&oldid=1856209438"